This is a non-core endpoint: only basic statistics are computed.
Polyclonal hypergammaglobulinaemia
D3_POLYCLOHYPERGAMMA
No definition available.
Endpoint definition
↥429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
35
Check minimum number of events None
35
Include endpoints None
35
Remove individuals based on genotype QC
33
Control definitions
Extra metadata
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to Polyclonal hypergammaglobulinaemia based on the number of shared cases.
Broader endpoints:
- Other disorders involving the immune mechanism, not elsewhere classified
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Paracetamol of NSAID medication
- Any operation in hilmo
Narrower endpoints:
None
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 33 | 15 | 18 |
Unadjusted prevalence (%) | 0.01 | 0.01 | 0.01 |
Mean age at first event (years) | 52.39 | 44.54 | 58.94 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: D3_POLYCLOHYPERGAMMA – Polyclonal hypergammaglobulinaemia
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Polyclonal hypergammaglobulinaemia
↥Endpoint not on priority list, no data to show.